Navigation Links
GeoVax Labs, Inc. Comments on Discontinuance of Merck's HIV Vaccine Trial
Date:9/24/2007

p>

GeoVax AIDS vaccines are being prepared to enter Phase 2 human trials. These large trials will expand the safety and positive immune response data demonstrated in the five (5) prior GeoVax AIDS vaccine trial groups. These trials will be conducted in collaboration with the HIV Vaccine Trials Network.

On the basis of non-human primate studies, GeoVax believes its vaccines will be safe and protective. A rigorously conducted clinical trial in human volunteers will be accomplished to confirm effectiveness in preventing AIDS. With 14,000 new HIV/AIDS infections reported daily and more than 60 million people living with HIV/AIDS worldwide, the need for an effective HIV/AIDS vaccine is extremely urgent.

Note: The US Food and Drug Administration (FDA) has established and oversees the regulatory guidelines for clinical trials in the United States and requires regular reports on the progress of clinical trials. The HIV Vaccine Trials Network provides a unifying structure for trials of candidate HIV/AIDS vaccines.

About GeoVax Labs, Inc. (http://www.geovax.com)

GeoVax Labs, Inc. is a biotechnology company, established to develop, manufacture, license and commercialize human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents. GeoVax's vaccine technology is protected by 20 filed patent applications and issued patents.

GeoVax HIV/AIDS vaccines are designed to prevent development of Acquired Immunodeficiency Disease (AIDS), caused by the virus known as HIV-1, by vaccinating individuals prior to their infection with the AIDS virus. GeoVax vaccine regimens employ a "prime-boost" strategy where its DNA vaccine "primes" the immune response and is followed by administration of the GeoVax MVA (Modified Vaccinia Virus) booster vaccination. Both vaccines deliver over 50% of the AIDS virus components but cannot cause AIDS. In addition, GeoVax AIDS vaccines may b
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
2. DOR BioPharma Announces Issuance of European Patent for Its Oral Multivalent Botulinum Toxin Vaccine BT-VACC
3. From Clinical Cancer Research: Rethinking Therapeutic Cancer Vaccine Trials
4. DOR BioPharma Announces Publication Describing Results of Its Multivalent Botulinum Toxin Vaccine BT-VACC
5. Vaccine Can Prevent Cervical Cancer and Precancerous Lesions
6. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
7. Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkins Lymphoma
8. HepaLifes PBS-1 Cells for Influenza Vaccine Production Prove Superior at International Conference
9. New Flu Vaccine from PepTcell Could Provide Immunity Against All Strains of Influenza Virus
10. Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure Reduction During Important Early Morning Period When Most Adverse Cardiovascular Events Occur
11. New Flu Vaccine From PepTcell Could Provide Immunity Against All Strains of Influenza Virus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... , Aug. 20, 2014   Ventana Medical ...  Group, today announced that its VENTANA System for ... in the European Union for routine pathology, including ... consisting of VENTANA Virtuoso software coupled with either ... HT slide scanner, provides automated digital slide creation, ...
(Date:8/20/2014)... and PHOENIX , ... established to bring cutting-edge next-generation sequencing and proteomic ... patients, today announced a collaboration with TESARO, Inc.  ... characterize patient tissue samples from clinical trials to ... resistant to TESARO,s TSR-011.  This may lead to more ...
(Date:8/20/2014)... , Aug. 20, 2014 Reportlinker.com announces that ... catalogue: Global Feminine Hygiene Products Industry ... analyzes the worldwide markets for Feminine Hygiene Products in ... Tampons, Panty liners, and Others. The report provides separate ... , Japan , Europe ...
Breaking Medicine Technology:Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis 2Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis 3Paradigm Announces Molecular Profiling Collaboration with TESARO, Inc. 2Global Feminine Hygiene Products Industry 2Global Feminine Hygiene Products Industry 3Global Feminine Hygiene Products Industry 4Global Feminine Hygiene Products Industry 5Global Feminine Hygiene Products Industry 6Global Feminine Hygiene Products Industry 7Global Feminine Hygiene Products Industry 8Global Feminine Hygiene Products Industry 9Global Feminine Hygiene Products Industry 10Global Feminine Hygiene Products Industry 11Global Feminine Hygiene Products Industry 12Global Feminine Hygiene Products Industry 13Global Feminine Hygiene Products Industry 14Global Feminine Hygiene Products Industry 15Global Feminine Hygiene Products Industry 16Global Feminine Hygiene Products Industry 17Global Feminine Hygiene Products Industry 18Global Feminine Hygiene Products Industry 19Global Feminine Hygiene Products Industry 20Global Feminine Hygiene Products Industry 21Global Feminine Hygiene Products Industry 22Global Feminine Hygiene Products Industry 23Global Feminine Hygiene Products Industry 24Global Feminine Hygiene Products Industry 25Global Feminine Hygiene Products Industry 26
(Date:8/20/2014)... has been chosen by Plymouth University to be an ... April 2009 to raise awareness of, and funding for, ... brain tumour patients. , A range of events and ... the charity, and members of staff and students, as ... donate, fundraise and volunteer. The involvement of the wider ...
(Date:8/20/2014)... 20, 2014 According to a ... technology (Electrochromics, SPD, Liquid Crystal, Microblinds, Thermographic and ... Electronics & others), by geography - Global Forecast ... value of Smart glass market was worth $1581.4 ... $5814 Million by 2020, at an estimated CAGR ...
(Date:8/20/2014)... Fresh from the cradle of a world-class running city, an ... , Urbini, a new collection of versatile baby gear from ... jogger to its lineup. , The Avi has been in ... the latest racing styles and a set of features to ... a swift, smooth ride on runs, power-walks and causal strolls. ...
(Date:8/20/2014)... Doctors at the University of Hong Kong claim to have ... by injecting them with a vaccine that changes their DNA. ... its website. Click here to read the full article ... of Microbiology created a vaccine using a protein called “programmed ... vaccine is designed to prevent mesothelioma cells from disabling the ...
(Date:8/20/2014)... Milwaukee, WI (PRWEB) August 20, 2014 ... ready. While the transition from summer months means buying ... important element that is often a forgotten part of ... health. , According to the American Psychological Association, 27% ... school year. Nearly half (45%) say they are stressed ...
Breaking Medicine News(10 mins):Health News:Plymouth University chooses Brain Tumour Research as official charity 2Health News:Smart Glass Market by Technology Worth $5814 Million by 2020 – New Report by MarketsandMarkets 2Health News:Smart Glass Market by Technology Worth $5814 Million by 2020 – New Report by MarketsandMarkets 3Health News:Smart Glass Market by Technology Worth $5814 Million by 2020 – New Report by MarketsandMarkets 4Health News:Smart Glass Market by Technology Worth $5814 Million by 2020 – New Report by MarketsandMarkets 5Health News:Urbini Breezes Through Summer with New Jogging Stroller 2Health News:New Research Study Finds Vaccine Stops Mesothelioma in Lab Mice, According to Surviving Mesothelioma Website 2Health News:Five Easy Steps to Help Your Child Manage Back-to-school Stress 2Health News:Five Easy Steps to Help Your Child Manage Back-to-school Stress 3
... session of,the New York Court of Appeals on October ... year and an economic tsunami, this state,s top,court, the ... the appeal of,Kathryn Jordan v. Bates Advertising 118785-99, an ... Sclerosis. The appeal was,filed by Jordan after the First ...
... yet another sign of,Kansas, leadership in addressing global challenges ... scientists from around the globe are,coming together this week ... diseases, which are diseases that can be transmitted,from animals ... from as far away as Japan,Israel, The Netherlands, Italy, ...
... by the U.S. Food and Drug Administration (FDA) for a new ... moderate to severe postmenopausal dyspareunia (painful sexual intercourse) announced Wyeth Pharmaceuticals, ... ... Pa. (Business Wire EON) November 13, 2008 -- "This approval ...
... Nov. 13 At a time when industry,retrenchment, ... a specialty,pharmaceutical company located outside Philadelphia is experiencing ... establishment,of a new division, FemmePharma Mental Healthcare, Central ... (CNS) disorders in women., "We are energized ...
... had nutrients that didn,t contain it, researchers say , , THURSDAY, ... fast-food meals begin with a single ingredient: corn. , Researchers ... and Burger King. , "We found that corn is not ... it is the basis of all fast food," said study ...
... join forces to provide superior customer care, ... Vendor,Service announced today that it will form a ... leaders in the ultrasound transducer repair,industry., (Logo: ... together two of the most reputable,high-quality service providers ...
Cached Medicine News:Health News:Top NY Court Blinks in 'First Department' WPP Discrimination Power Play 2Health News:Top NY Court Blinks in 'First Department' WPP Discrimination Power Play 3Health News:Top NY Court Blinks in 'First Department' WPP Discrimination Power Play 4Health News:Top NY Court Blinks in 'First Department' WPP Discrimination Power Play 5Health News:Leading Scientists From Around the World Headed to Kansas for Symposium on Combating Deadly Infectious Diseases 2Health News: FDA Approves Low-dose Regimen of PREMARIN Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia – Painful Sexual Intercourse : Agency Grants New Indication for Bothersome Vaginal Symptom Associated with Menopause 2Health News: FDA Approves Low-dose Regimen of PREMARIN Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia – Painful Sexual Intercourse : Agency Grants New Indication for Bothersome Vaginal Symptom Associated with Menopause 3Health News: FDA Approves Low-dose Regimen of PREMARIN Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia – Painful Sexual Intercourse : Agency Grants New Indication for Bothersome Vaginal Symptom Associated with Menopause 4Health News:In a Down Economy, Women's Health Company Announces Growth 2Health News:Traces of Corn Found in Almost All Fast Food 2Health News:MEDRAD Multi Vendor Service Forms Alliance with Wetsco 2Health News:MEDRAD Multi Vendor Service Forms Alliance with Wetsco 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: